Calciparin

Calciparin: direct acting anticoagulant

Calciparin is a direct-acting anticoagulant manufactured by Sanofi Winthrop Industrie in France. It is an injection solution available in two forms: 12500 IU and 5000 IU. The international name of calciparin is heparin calcium, and it is also known under the synonyms heparibene calcium.

Calciparin is intended for the prevention and treatment of thrombosis and embolism associated with various diseases. Direct anticoagulants, such as calciparin, prevent blood clotting by inhibiting a clotting factor (thrombin), which is necessary for the formation of blood clots.

Calciparin can be prescribed to patients with thrombosis, embolism, a high risk of thromboembolic complications, as well as during certain surgical operations. The dosage and duration of treatment should be determined by the doctor depending on the severity of the disease and the individual sensitivity of the patient.

Calciparin, like any other medicine, can cause unwanted effects such as bleeding, allergic reactions and others. Before starting treatment, you should discuss the potential risks and benefits of calciparin with your doctor.

In conclusion, calciparin is a direct-acting anticoagulant that is used for the prevention and treatment of thrombosis and embolism. It is manufactured by Sanofi Winthrop Industrie in France and is available in two forms: 12500 IU and 5000 IU. Treatment with calciparin should be carried out under the supervision of a physician, who will determine the dosage and duration of treatment depending on the severity of the disease and the individual sensitivity of the patient.